Paper into Mesothelioma Research published in the Lancet Respiratory Medicine

Delighted to see that a paper into the outcome of the MiST 1 work in mesothelioma research, part funded by Victor Dahdaleh Foundation, was recently published in the Lancet Respiratory Medicine. It is encouraging to see positive news in this specialist area of research and the benefits of an innovative trials approach. Full details of the Paper can be found here.

01/02/2021

LATEST NEWS

McGill University receives landmark donation from alumnus Victor Phillip Dahdaleh to create new Institute of Genomic Medicine


A landmark donation to support McGill University’s renowned genomics research and education programs from UK-based alumnus and long-time donor Victor Dahdaleh will be a catalyst for advancements in genomics research. Thanks to gifts from Mr. Dahdaleh totalling more than $30 million, McGill will launch the Victor Phillip Dahdaleh Institute of Genomic Medicine. For more details see […]

25/10/2022

The Victor Dahdaleh Foundation to support University facilities, selected programming with $4M gift


The gift will support upgrades to the Victor Phillip Dahdaleh Building on York University’s Keele Campus, provide operating funding to CIFAL York and support a new operations facility for the Advanced Disaster, Emergency and Rapid Response Simulation initiative. York was honoured to welcome alumnus and philanthropist Victor Dahdaleh and his wife Mona to campus to celebrate the Victor Dahdaleh Foundation’s new $4-million gift to […]

25/10/2022

Victor Dahdaleh Foundation proud to support mesothelioma research


Mesothelioma is an aggressive cancer usually caused by breathing in asbestos dust. Most of the cases affect people’s lungs but it can strike in other parts of the body.  With only 7% of those diagnosed surviving more than 5 years, the condition tragically causes 2,394 deaths a year in the UK.   As the UK’s leading […]

04/07/2022